Production (Stage)
BioSig Technologies, Inc.
BSGM
$5.23
-$0.63-10.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 8.33% | -- | -- | 180.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 8.33% | -- | -- | 180.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 8.33% | -- | -- | 180.00% |
| SG&A Expenses | 2.60% | -78.21% | -1.85% | -46.04% | -53.85% |
| Depreciation & Amortization | -73.08% | -67.74% | -66.30% | -46.74% | -7.14% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.69% | -80.64% | -27.20% | -51.37% | -56.73% |
| Operating Income | 6.28% | 80.82% | 27.18% | 51.49% | 56.89% |
| Income Before Tax | 18.01% | 82.07% | 52.74% | 64.86% | 53.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.01% | 82.07% | 52.74% | 64.86% | 53.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -192.31% | -100.00% | -- | -110.81% | -74.00% |
| Net Income | 17.34% | 81.83% | 58.09% | 64.71% | 53.60% |
| EBIT | 6.28% | 80.82% | 27.18% | 51.49% | 56.89% |
| EBITDA | 4.60% | 81.02% | 26.27% | 51.53% | 57.46% |
| EPS Basic | 62.27% | 90.64% | 80.25% | 80.79% | 69.73% |
| Normalized Basic EPS | 54.47% | 89.88% | 72.01% | 73.93% | 73.00% |
| EPS Diluted | 62.27% | 90.64% | 80.25% | 80.79% | 69.73% |
| Normalized Diluted EPS | 54.47% | 89.88% | 72.01% | 73.93% | 73.00% |
| Average Basic Shares Outstanding | 110.91% | 97.59% | 114.95% | 83.78% | 59.31% |
| Average Diluted Shares Outstanding | 110.91% | 97.59% | 114.95% | 83.78% | 59.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |